The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients

Khalil Ahmed; Chhabra Anita; Merchak Andrea; Kahn Larry; Leventhal Joseph; Ildstad Suzanne

首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients

【24h】

The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients

机译：CTLA4至Perforin和Granzyme B的比例作为嵌合肾移植患者耐受性的潜在生物标志物

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Transplantation: Official Journal of the Transplantation Society》 |2018年第9suppla期|共2页
作者
Khalil Ahmed; Chhabra Anita; Merchak Andrea; Kahn Larry; Leventhal Joseph; Ildstad Suzanne;
展开▼
作者单位

Univ Louisville Inst Cellular Therapeut Louisville KY 40292 USA;

Univ Louisville Inst Cellular Therapeut Louisville KY 40292 USA;

Univ Louisville Inst Cellular Therapeut Louisville KY 40292 USA;

Univ Louisville Inst Cellular Therapeut Louisville KY 40292 USA;

Northwestern Univ Chicago IL 60611 USA;

Univ Louisville Inst Cellular Therapeut Louisville KY 40292 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类器官移植术;
关键词

相似文献

外文文献
中文文献
专利

1. The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients [J] . Khalil Ahmed, Chhabra Anita, Merchak Andrea, Transplantation: Official Journal of the Transplantation Society . 2018,第9Suppla期

机译：CTLA4至Perforin和Granzyme B的比例作为嵌合肾移植患者耐受性的潜在生物标志物
2. Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients [J] . Kaufeld Jessica K., Gwinner Wilfried, Scheffner Irina, Journal of Transplantation . 2012,第4期

机译：尿NGAL比率不是监测肾移植患者急性肾小管损伤的敏感生物标志物：肾移植患者的NGAL和ATI
3. Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients [J] . DugastE., ChesneauM., SoulillouJ.-P., Immunological reviews. . 2014,第Null期

机译：肾移植患者的生物标志物和操作耐受性的可能机制
4. Role of Integrating Diffusion Mr Image-Markers with Clinical-Biomarkers For Early Assessment of Renal Transplants [C] . Mohammad Shehata, Mohammed Ghazal, Garth Beache, IEEE International Conference on Image Processing . 2018

机译：扩散Mr图像标记物与临床生物标记物整合在肾移植早期评估中的作用
5. A Retrospective Analysis of Renal Transplant Outcomes: induction Immunosuppression with Anti-thymocyte Globulin vs. Alemtuzumab in patients undergoing Deceased and Living Donor Kidney Transplantation. [D] . DiMartino, Debra A. 2012

机译：肾移植结果的回顾性分析：死者和活体供者肾脏移植患者中抗胸腺细胞球蛋白与Alemtuzumab的诱导免疫抑制作用。
6. Non-Chimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers [O] . J.R. Leventhal, J.M. Mathew, D.R. Salomon, -1

机译：非嵌合HLA相同的肾移植耐受性：调节免疫表型/基因组生物标志物。
7. Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation [O] . Welberry Smith Matthew P., Zougman Alexandre, Cairns David A., 2013

机译：血清氨酰酶-1是一种新型生物标志物，对于肾移植后移植物功能延迟的患者具有长期预后的潜在预后效用

The Ratio of CTLA4 to Perforin and Granzyme B as a Potential Biomarker of Tolerance in Chimeric Renal Transplant Patients

著录项

相似文献

相关主题

期刊订阅